eMedicine Specialties > Ophthalmology > Neurologic Disorders
Bell Palsy: Treatment & Medication
Updated: Oct 30, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Treatment
Medical Care
- Systemic therapy
- Evidence has shown that early corticosteroid use for Bell palsy improves outcome in patients, whereas antiviral therapy fails to demonstrate any significant beneficial effect. A double-blind, randomized trial of 551 patients with Bell palsy recruited within 72 hours of the onset of symptoms demonstrated that early treatment with prednisolone significantly improved the chances of complete recovery at 3 and 9 months. In contrast, acyclovir given alone did not show any significant difference in the rate of facial recovery compared to placebo, and there was no additional benefit from combining acyclovir and prednisolone compared to prednisolone alone. A larger double-blind, controlled trial showed that prednisolone significantly shortened the time to complete recovery, whereas valacyclovir did not affect facial recovery compared to placebo.4,5
- Quant et al conducted a meta-analysis of published studies from 1984 to January 2009 to compare use of corticosteroids plus antiviral agents with corticosteroids alone on degree of facial muscle recovery in patients with Bell palsy.14 Six trials (representing pooled data of 1145 patients) were examined and included 574 patients who received corticosteroids alone and 571 patients who received corticosteroids and antiviral agents. The analysis showed no improved benefit for Bell palsy with use of corticosteroids plus antivirals compared with corticosteroids alone (odds ratio 1.50; 95% confidence interval [CI], 0.83-2.69; P=0.18). The authors suggest the routine use of antivirals is not warranted; however, future studies should improve diagnostic efforts to identify herpes virus as a potential etiology. Additionally, newer antiviral agents may prove more beneficial than older antiviral agents used in the studies analyzed.
- Local therapy
- In most cases, topical ocular lubrication (with artificial tears during the day and lubricating ophthalmic ointment at night, or occasionally ointment day and night) is sufficient to prevent the complications of corneal exposure.15
- Occluding the eyelids by using tape or by applying a patch for 1 or 2 days may help to heal corneal erosions. Care must be taken to prevent worsening the abrasion with the tape or a patch by ensuring that the eyelid is securely closed.
- External eyelid weights are available to improve mechanical blink. The weights are attached to the upper lid with an adhesive and are available in different skin tones.
- Clear plastic wrap, cut to 8 X 10 cm and applied with generous amounts of ointment as a nighttime occlusive bandage, may be required.
- Lower-lid ectropion or droop can temporarily be helped by applying tape below the lid margin in the center of the lower lid; pull the lid laterally and upward to anchor on the orbital rim.
- Punctal plugs may be helpful if dryness of the cornea is a persistent problem.
- Botulinum toxin can be injected transcutaneously or subconjunctivally at the upper border of the tarsus and aimed at the levator muscle to produce complete ptosis and to protect the cornea.11
- Botulinum toxin may help in relaxing the facial muscles after they have developed mass contraction, though the results are not as satisfying as in patients with Bell palsy as in patients with idiopathic hemifacial spasm.
Surgical Care
Surgery to decompress the facial nerve is controversial when performed in patients with complete Bell palsy that has not responded to medical therapy and with greater than 90% axonal degeneration, as shown on facial-nerve EMG within 3 weeks of the onset of paralysis.16,13 The problem must be localized with MRI; then, the surgeon can decide if the maxillary segment should be decompressed externally or if the labyrinthine segment and geniculate ganglion should be decompressed by way of a middle-fossa craniotomy.
- Procedures to correct lower lid droop and ectropion
- The suborbicularis oculi fat (SOOF) lift is designed to lift and suspend the midfacial musculature. The SOOF is deep to the orbicularis oculi muscle and superficial to the periosteum below the inferior orbital rim. Lifting the SOOF may also elevate the upper lip and the angle of the mouth to improve facial symmetry. A SOOF lift is commonly done in conjunction with a lateral tarsal strip procedure to tighten the eyelid.17
- A lateral tarsal strip procedure is performed to correct horizontal lower-lid laxity and to improve apposition of the lid to the globe. First, lateral canthotomy and cantholysis is performed. Then, the anterior lamella is removed, and the lateral tarsal strip is shortened and attached to the periosteum at the lateral orbital rim.
- Procedures to correct lagophthalmos
- Implantable devices have been used to restore dynamic lid closure in cases of severe, symptomatic lagophthalmos. These procedures are best for patients with poor Bell phenomenon and decreased corneal sensation. Gold or platinum weights, a weight-adjustable magnet, or palpebral springs can be inserted into the eyelids. Pretarsal gold-weight implantation is most commonly performed. The weight allows the upper eyelid to close with gravity when the levator palpebrae is relaxed. Therefore, patients must sleep with their head slightly elevated. The implants are inert and composed of 99.99% pure gold or platinum. Sizes range from 0.6-1.8 g. They are easily removed if nerve function returns. Complications include migration of the implant, inflammation, allergic reaction, or extrusion.
- Tarsorrhaphy decreases horizontal lid opening by fusing the eyelid margins together to improve support of the precorneal lake of tears and to improve coverage of the eye during sleep. The procedure can be done in the office and is particularly suitable for patients who are unable or unwilling to undergo other surgery. Tarsorrhaphy can be performed laterally, centrally, or medially. The lateral procedure is most common; however, it can restrict the monocular temporal visual field. Central tarsorrhaphy offers good corneal protection, but it occludes vision and can be cosmetically unacceptable. Medial or paracentral tarsorrhaphy is performed lateral to the lacrimal puncta and can offer good lid closure without substantially affecting the visual field. The procedures can be completed as temporary or permanent measures. Permanent tarsorrhaphy is done if nerve recovery is not expected.
- Transposition of the temporalis muscle can be used to reanimate the face and to provide lid closure by using the fifth cranial nerve. Strips from the muscle and fascia are placed in the upper and lower lids as an encircling sling. Patients initiate movement by chewing or clenching their teeth.
- Reinnervation of the facial nerve by means of facial nerve grafting or hypoglossal-facial nerve anastomosis can be used in cases of clinically significant permanent paralysis to help restore relatively normal function to the orbicularis oculi muscle or eyelids.
- Brow ptosis is repaired with a direct brow lift. Care should be taken in the presence of corneal decompensation because lifting the brow can cause worsening of lagophthalmos, especially if lid closure is poor. A gold-weight implant can be placed or lower-lid resuspension can be performed simultaneously to prevent this complication.
- In the author’s experience, surgical repair by using a combination of procedures tailored to the patients' clinical findings works well for improving symptoms and exposure. Most patients who have had severe corneal exposure due to lagophthalmos with or without paralytic ectropion received a combination of lateral tarsal strip placement, SOOF lift, and gold-weight implantation. Patients without severe exposure have received a single procedure or combinations of procedures.
Consultations
Depending on the workup results and clinical course, consultations with the following specialists may be indicated:
- Neurologist: An evaluation with a neurologist may be indicated for patients with a prolonged course, abnormal imaging studies, or inconsistencies in the findings on neurologic examination.
- Infectious disease specialist: An evaluation by a specialist in infectious disease may be indicated if results of laboratory studies are positive for Lyme disease, syphilis, or HIV infection.
- Ear, nose, and throat specialist: An evaluation with an otolaryngologist may be indicated for patients with a prolonged course for the consideration of surgical decompression of the facial nerve.
Medication
The goal of pharmacotherapy is to reduce morbidity by shortening the recovery time and preventing long-term complications.18,19
Corticosteroids
Corticosteroids may be beneficial in decreasing swelling and inflammation of the facial nerve. They have anti-inflammatory properties and cause profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.
Prednisone (Deltasone, Orasone, Sterapred)
May decrease inflammation by reversing increased capillary permeability and suppressing activity of polymorphonuclear (PMN) leukocytes.
Adult
60-80 mg PO qd for 4-7 d or 1 mg/kg/d PO for 4-7 d; dose usually tapered and discontinued over 10 d
Pediatric
1 mg/kg/d PO for 5-7 d; taper as above
Coadministration with estrogens may decrease clearance; with digoxin, digitalis toxicity secondary to hypokalemia may increase; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics
Documented hypersensitivity; viral infection, peptic ulcer disease, hepatic dysfunction, connective tissue infections, and fungal or tubercular skin infections
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Abrupt discontinuation of long-term glucocorticoids may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur with glucocorticoid use
Antiviral agents
Use of these agents is controversial, but many cases of Bell palsy may be correlated with herpes simplex infection; therefore, an antiviral may be beneficial.
Acyclovir (Zovirax)
Inhibits activity of HSV-1 and HSV-2. Use within 48 h of rash onset decreases pain and speeds resolution of cutaneous lesions. May prevent recurrent outbreaks.
Adult
400-800 mg PO tid to 5 times/d for 7 d
Pediatric
<2 years: Not recommended
>2 years: 20 mg/kg PO tid
Concomitant probenecid or zidovudine prolongs half-life and increases CNS toxicity
Documented hypersensitivity
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Caution in renal failure or with nephrotoxic drugs
Valacyclovir (Valtrex)
Prodrug rapidly converted to active drug acyclovir. More expensive than acyclovir but has more convenient dosing and better bioavailability.
Adult
1000 mg PO tid for 7 d
Pediatric
Not established
Probenecid, zidovudine, or cimetidine coadministration prolongs half-life and increases CNS toxicity
Documented hypersensitivity
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
Adverse reactions include thrombocytopenia, facial edema, rash, urticaria, and GI upset; caution in renal failure and coadministration of nephrotoxic drugs; rarely associated with hemolytic-uremic syndrome if given in massive dose; thousands of pregnancies documented in the acyclovir registry and hundreds in the valacyclovir and famciclovir registries without reports of increased fetal defects or difficulties in pregnancy due to these drugs
More on Bell Palsy |
| Overview: Bell Palsy |
| Differential Diagnoses & Workup: Bell Palsy |
Treatment & Medication: Bell Palsy |
| Follow-up: Bell Palsy |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Peitersen E. The natural history of Bell's palsy. Am J Otol. Oct 1982;4(2):107-11. [Medline].
Hashisaki GT. Medical management of Bell's palsy. Compr Ther. Nov 1997;23(11):715-8. [Medline].
Adour KK, Byl FM, Hilsinger RL Jr, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope. May 1978;88(5):787-801. [Medline].
Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. Oct 18 2007;357(16):1598-607. [Medline].
Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. Nov 2008;7(11):993-1000. [Medline].
Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology. Jul 1992;42(7):1268-70. [Medline].
Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4-30. [Medline].
Vrabec JT, Backous DD, Djalilian HR, Gidley PW, Leonetti JP, Marzo SJ. Facial Nerve Grading System 2.0. Otolaryngol Head Neck Surg. Apr 2009;140(4):445-50. [Medline].
Liu J, Li Y, Yuan X, Lin Z. Bell's palsy may have relations to bacterial infection. Med Hypotheses. Feb 2009;72(2):169-70. [Medline].
Gordon SC. Bell's palsy in children: role of the school nurse in early recognition and referral. J Sch Nurs. Dec 2008;24(6):398-406. [Medline].
Seiff SR, Chang J. Management of ophthalmic complications of facial nerve palsy. Otolaryngol Clin North Am. Jun 1992;25(3):669-90. [Medline].
Murphy TP. MRI of the facial nerve during paralysis. Otolaryngol Head Neck Surg. Jan 1991;104(1):47-51. [Medline].
Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med. Sep 23 2004;351(13):1323-31. [Medline].
[Best Evidence] Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ. 2009;339:b3354. [Medline].
Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ. Sep 4 2004;329(7465):553-7. [Medline].
Julian GG, Hoffmann JF, Shelton C. Surgical rehabilitation of facial nerve paralysis. Otolaryngol Clin North Am. Oct 1997;30(5):701-26. [Medline].
Olver JM. Raising the suborbicularis oculi fat (SOOF): its role in chronic facial palsy. Br J Ophthalmol. Dec 2000;84(12):1401-6. [Medline].
Gilden D. Treatment of Bell's palsy--the pendulum has swung back to steroids alone. Lancet Neurol. Nov 2008;7(11):976-7. [Medline].
Engstrom M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. Nov 2008;7(11):993-1000. [Medline].
Sathirapanya P, Sathirapanya C. Clinical prognostic factors for treatment outcome in Bell's palsy: a prospective study. J Med Assoc Thai. Aug 2008;91(8):1182-8. [Medline].
Bauer CA, Coker NJ. Update on facial nerve disorders. Otolaryngol Clin North Am. Jun 1996;29(3):445-54. [Medline].
Chua CN, Quhill F, Jones E, Voon LW, Ahad M, Rowson N. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. Dec 2004;23(4):213-8. [Medline].
Davies R. Facial nerve palsy. In: Levine M, ed. Manual of Oculoplastic Surgery. 2003. Butterworth-Heinemann: Boston, MA; 197-202.
English JB, Stommel EW, Bernat JL. Recurrent Bell's palsy. Neurology. Aug 1996;47(2):604-5. [Medline].
Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Apr 10 2001;56(7):830-6. [Medline].
Jackson CG, von Doersten PG. The facial nerve. Current trends in diagnosis, treatment, and rehabilitation. Med Clin North Am. Jan 1999;83(1):179-95, x. [Medline].
Lee V, Currie Z, Collin JR. Ophthalmic management of facial nerve palsy. Eye. Dec 2004;18(12):1225-34. [Medline].
Williamson IG, Whelan TR. The clinical problem of Bell's palsy: is treatment with steroids effective?. Br J Gen Pract. Dec 1996;46(413):743-7. [Medline].
Further Reading
Related eMedicine topics
Bell Palsy (from Neurology)
Bell Palsy (from Emergency Medicine)
Bell Palsy (from Otolaryngology and Facial Plastic Surgery)
Congenital Facial Paralysis
Static Suspension for Facial Paralysis
Clinical studies
Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages
Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery
Keywords
Bell palsy, Bell's palsy, facial nerve paralysis, idiopathic facial palsy
Treatment & Medication: Bell Palsy